Emulate
PrivateLast Round
Series E
Sep 7, 2021
Total Funding Raised
$175M
Company Overview
Emulate is a biotechnology company that offers an automated bio-emulation platform to accurately predict human responses to diseases, medicines, chemicals, and foods by integrating micro-engineering with living human cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emulate Comps
Public and private peers based on sector, stage, and business model.
Emulate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 7, 2021 | ||||
| Series C | Jun 19, 2018 | ||||
| Series B Extension | Oct 20, 2016 | ||||
| Series B | Mar 28, 2016 | ||||
| Series A | Jul 28, 2014 |
Emulate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SciFi Ventures | Series C |
| Perceptive Advisors | Series E |
| Founders Fund | Series C |
| ALS Investment Fund | Series C |
| OS Fund | Series B, Series B Extension |
| ATEL Capital Group | Series B |
| GlassWall Syndicate | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Liver-Chip BioKit validated under FDA's ISTAND program.
- Feb 27, 2026
Attended SLAS 2026 and won a New Product Award.
Emulate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Emulate's valuation, stock price, and market status.
